Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  American Journal of Clinical Pathology

• Publication date

  2009-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1309/AJCP86PPBNGOHNNLPMID 19289585
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global cancer statistics

  2011cited by this paper
• Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

  2008cited by this paper
• Selection of reference genes for real-time PCR in human hepatocellular carcinoma tissues

  2008cited by this paper
• High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma.

  2008cited by this paper
• Clinical Implications of Fibroblast Activation Protein in Patients with Colon Cancer

  2007cited by this paper
• ICAM‐1 expressed on hepatic stellate cells plays an important role in immune regulation

  2007cited by this paper
• Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma.

  2007cited by this paper
• Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis

  2007cited by this paper
• Expression of large tenascin-C splice variants by hepatic stellate cells/myofibroblasts in chronic hepatitis C.

  2007cited by this paper
• Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

  2007cited by this paper
• Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells.

  2007cited by this paper
• Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma.

  2007cited by this paper
• In vivo immune modulatory activity of hepatic stellate cells in mice

  2006cited by this paper
• Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.

  2006cited by this paper
• Activated hepatic stellate cells induce tumor progression of neoplastic hepatocytes in a TGF‐β dependent fashion

  2006cited by this paper
• Dendritic cell infiltration and prognosis of human hepatocellular carcinoma

  2006cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients.

  2005cited by this paper
• Collagen type IV, laminin, α-smooth muscle actin (αSMA), α1 and α6 integrins expression in the liver with metastases from malignant gastrointestinal tumours

  2004cited by this paper
• Collagen type IV, laminin, alpha-smooth muscle actin (alphaSMA), alpha1 and alpha6 integrins expression in the liver with metastases from malignant gastrointestinal tumours.

  2004cited by this paper
• ADAM12 in human liver cancers: TGF‐β‐regulated expression in stellate cells is associated with matrix remodeling

  2003cited by this paper
• Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting

  2003cited by this paper
• Proangiogenic role of tumor‐activated hepatic stellate cells in experimental melanoma metastasis

  2003cited by this paper
• Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection.

  2003cited by this paper
• Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection.

  2002cited by this paper
• Expression of SPARC by activated hepatic stellate cells and its correlation with the stages of fibrogenesis in human chronic hepatitis

  2002cited by this paper
• Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.

  2002cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers.

  2001cited by this paper
• Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival.

  2000cited by this paper
• Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma

  2000cited by this paper
• Fibroblast activation protein: A cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis

  1999cited by this paper
• Activation of cultured rat hepatic stellate cells by tumoral hepatocytes.

  1999cited by this paper
• Tumor‐dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis

  1997cited by this paper
• Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: Evidence for a role of hepatocyte growth factor

  1997cited by this paper
• Autonomic neuropathy in extra-hepatic portal vein thrombosis: evidence for impaired autonomic reflex arc.

  1997cited by this paper
• Alpha-smooth muscle actin-positive perisinusoidal stromal cells in human hepatocellular carcinoma.

  1994cited by this paper
• α‐Smooth muscle actin–positive perisinusoidal stromal cells in human hepatocellular carcinoma

  1994cited by this paper
• Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines.

  1993cited by this paper
• Growth and spread of hepatocellular carcinoma: A review of 240 consecutive autopsy cases

  1990cited by this paper
• Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies

  1954cited by this paper
• Breast Cancer Res Treat (2008) 107:249–257 DOI 10.1007/s10549-007-9546-3 PRECLINICAL STUDY Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases

  year unknowncited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

  year unknowncited by this paper

• Multi-omics profiling reveals cholic acid-mediated immunosuppression driven by peritumoral ductular reactions in hepatocellular carcinoma.

  2026cites this paper
• Quantitative Calibration of a Spatial QSP Model Identifies Fibroblast Impact on HCC Immunotherapy

  2025cites this paper
• MTFR2‐Mediated Fission Drives Fatty Acid and Mitochondrial Co‐Transfer from Hepatic Stellate Cells to Tumor Cells Fueling Oncogenesis

  2025cites this paper
• Hepatocellular Cancer Surveillance in Patients with Advanced Chronic Liver Disease.

  2024cites this paper
• Prognostic impact of CD68+ tumor-associated macrophages in hepatocellular carcinoma: A meta-analysis

  2024cites this paper
• Fibroblast activation protein promotes progression of hepatocellular carcinoma via regulating the immunity

  2024cites this paper
• Beyond Small Molecules: Antibodies and Peptides for Fibroblast Activation Protein Targeting Radiopharmaceuticals

  2024cites this paper
• Infiltrative vessel co-optive growth pattern induced by IQGAP3 overexpression promotes microvascular invasion in hepatocellular carcinoma.

  2024cites this paper
• Advancing Hepatocellular Carcinoma Management Through Peritumoral Radiomics: Enhancing Diagnosis, Treatment, and Prognosis

  2024influential citation
• Targeting fibroblast activation protein with chimeric antigen receptor macrophages.

  2024cites this paper
• Comprehensive analysis of cuproptosis-related prognostic gene signature and tumor immune microenvironment in HCC

  2023cites this paper
• Role of Immunological Cells in Hepatocellular Carcinoma Disease and Associated Pathways

  2023cites this paper
• The correlation between tumor-associated macrophages and the prognosis of east Asian hepatocellular carcinoma patients: A systematic review and meta-analysis.

  2023cites this paper
• Stiffness on shear wave elastography as a potential microenvironment biomarker for predicting tumor recurrence in HBV-related hepatocellular carcinoma

  2023cites this paper
• Proteomics of adjacent-to-tumor samples uncovers clinically relevant biological events in hepatocellular carcinoma

  2023cites this paper
• Fibroblast activation protein as a potential theranostic target in brain metastases of diverse solid tumours.

  2023cites this paper
• Role of 68Ga-FAPI PET/CT in Assessing Hepatobiliary Malignancies

  2023cites this paper
• Synthesis, radiolabeling, and evaluation of a (4-quinolinoyl)glycyl-2-cyanopyrrolidine analogue for fibroblast activation protein (FAP) PET imaging

  2023cites this paper
• Direct-acting antivirals sofosbuvir and daclatasvir attenuate carbon tetrachloride-induced liver fibrosis in mice

  2023cites this paper
• Single-cell transcriptomic analysis reveals a novel cell state and switching genes during hepatic stellate cell activation in vitro

  2022cites this paper
• 3D Biomimetic Tumor Microenvironment of HCC to Visualize the Intercellular Crosstalk Between Hepatocytes, Hepatic Stellate Cells, and Cancer Cells

  2022cites this paper
• Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?

  2022cites this paper
• Prognostic value of SPARC in hepatocellular carcinoma: A systematic review and meta-analysis

  2022influential citation
• The “stiff rim” sign of hepatocellular carcinoma on shear wave elastography: correlation with pathological features and potential prognostic value

  2022cites this paper
• Advancement and Future Perspective of FAPI PET/CT In Gynecological Malignancies.

  2022cites this paper
• Ultrasensitive Fibroblast Activation Protein-α-Activated Fluorogenic Probe Enables Selective Imaging and Killing of Melanoma In Vivo.

  2022cites this paper
• [68Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of gastric cancer: comparison with [18F]FDG PET/CT

  2022cites this paper
• Peritumoral histopathologic findings in patients with chronic viral hepatitis‐associated hepatocellular carcinoma

  2022cites this paper
• Predicting Genomic Alterations of Phosphatidylinositol-3 Kinase Signaling in Hepatocellular Carcinoma: A Radiogenomics Study Based on Next-Generation Sequencing and Contrast-Enhanced CT

  2022cites this paper
• CDCP1 Expression Is a Potential Biomarker of Poor Prognosis in Resected Stage I Non-Small-Cell Lung Cancer

  2022cites this paper
• The Role of Fibroblast Activation Protein Ligands in Oncologic PET Imaging.

  2021cites this paper
• [68Ga]Ga-DOTA-FAPI-04 PET/CT in The Staging of Gastric Cancer: Improved Diagnostic Efficacy Confirmed By Postoperative Histopathology

  2021cites this paper
• Is partial hepatectomy a curable treatment option for hepatocellular carcinoma accompanied by cirrhosis? A meta-analysis and cure model analysis

  2021cites this paper
• SPARC Overexpression Promotes Liver Cancer Cell Proliferation and Tumor Growth

  2021cites this paper
• Current Perspectives on the Immunosuppressive Niche and Role of Fibrosis in Hepatocellular Carcinoma and the Development of Antitumor Immunity

  2021cites this paper
• Elevated STIL predicts poor prognosis in patients with hepatocellular carcinoma

  2021cites this paper
• Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma

  2021cites this paper
• Histopathological growth patterns modify the prognostic impact of microvascular invasion in non-cirrhotic hepatocellular carcinoma.

  2021cites this paper
• In Vitro and In Situ Activity-Based Labeling of Fibroblast Activation Protein with UAMC1110-Derived Probes

  2021cites this paper
• Sulfatase 2-Induced Cancer-Associated Fibroblasts Promote Hepatocellular Carcinoma Progression via Inhibition of Apoptosis and Induction of Epithelial-to-Mesenchymal Transition

  2021cites this paper
• Cancer-Associated Fibroblasts as Players in Cancer Development and Progression and Their Role in Targeted Radionuclide Imaging and Therapy

  2021cites this paper
• Nanoparticle formulation of mycophenolate mofetil achieves enhanced efficacy against hepatocellular carcinoma by targeting tumour‐associated fibroblast

  2021cites this paper
• Myofibroblast‐Specific Msi2 Knockout Inhibits HCC Progression in a Mouse Model

  2021cites this paper
• Activated hepatic stellate cells promote angiogenesis in hepatocellular carcinoma by secreting angiopoietin‐1

  2020influential citation
• Immunological characterization of hepatocellular carcinoma

  2020cites this paper
• Evaluation and prediction of therapeutic response for patients with hepatocellular carcinoma receiving stereotactic body radiotherapy using serial computed tomography scans and radiomics

  2020cites this paper
• Peritumoral activated hepatic stellate cells are associated with hepatic recurrence for resectable colorectal adenocarcinoma liver metastasis following resection

  2020cites this paper
• Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using Nanocarriers

  2020cites this paper
• MicroRNA-142-5p is Up-regulated on Allogeneic Immune Responses and Up-regulates MHC Class II Expression in Human Umbilical Vein Endothelial Cells.

  2020cites this paper
• Interaction with CD68 and Regulation of GAS6 Expression by Endosialin in Fibroblasts Drives Recruitment and Polarization of Macrophages in Hepatocellular Carcinoma

  2020cites this paper
• Uveal melanoma pathobiology: metastasis to the liver.

  2020cites this paper
• SPARC Negatively Correlates With Prognosis After Transarterial Chemoembolization and Facilitates Proliferation and Metastasis of Hepatocellular Carcinoma via ERK/MMP Signaling Pathways

  2020cites this paper
• Origin and role of hepatic myofibroblasts in hepatocellular carcinoma

  2020cites this paper
• Hepatic Stellate Cell–Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis

  2020influential citation
• Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer

  2020cites this paper
• Role and mechanism of programmed death-ligand 1 in hypoxia-induced liver cancer immune escape

  2020cites this paper
• CD66b+ neutrophils and α‐SMA+ fibroblasts predict clinical outcomes and benefits from postoperative chemotherapy in gastric adenocarcinoma

  2020cites this paper
• Upregulation of amphiregulin by retinoic acid and Wnt signalling promotes liver cancer cell proliferation

  2020influential citation
• Hepatic stellate cells promote the progression of hepatocellular carcinoma through microRNA-1246-RORα-Wnt/β-Catenin axis.

  2020cites this paper
• Hepatic Stellate Cells in Liver Tumor.

  2020cites this paper
• Tumor Microenvironment: Non-Hematopoietic Cells

  2020cites this paper
• Hepatic Stellate Cells Contribute to the Tumor Malignancy of Hepatocellular Carcinoma Through the IL-6 Pathway

  2020cites this paper
• Targeting of activated fibroblasts for imaging and therapy

  2019cites this paper
• Pericytes in the Liver.

  2019cites this paper
• The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma

  2019cites this paper
• Peri-tumor fibroblasts promote tumorigenesis and metastasis of hepatocellular carcinoma via Interleukin6/STAT3 signaling pathway

  2019cites this paper
• Contributions of Fibroblasts, Extracellular Matrix, Stiffness, and Mechanosensing to Hepatocarcinogenesis

  2019cites this paper
• Hepatocellular Carcinoma: Translational Precision Medicine Approaches

  2019cites this paper
• Stromal and Immune Drivers of Hepatocarcinogenesis

  2019cites this paper
• The Immunobiology of Hepatocellular Carcinoma in Humans and Mice: Basic Concepts and Therapeutic Implications.

  2019cites this paper
• Clinicopathologic and prognostic significance of tumor-associated macrophages in patients with hepatocellular carcinoma: A meta-analysis

  2019cites this paper
• CMAR_A_192263 2889..2901

  2019cites this paper
• Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein

  2018cites this paper
• Real Academia Nacional de Medicina

  2018cites this paper
• A novel 12-marker panel of cancer-associated fibroblasts involved in progression of hepatocellular carcinoma

  2018cites this paper
• Prognostic value of tumor-infiltrating lymphocytes in hepatocellular carcinoma

  2018cites this paper
• Interaction of hepatic stellate cells with neutrophils and macrophages in the liver following oncogenic kras activation in transgenic zebrafish

  2018cites this paper
• The Expression of FAP in Hepatocellular Carcinoma Cells is Induced by Hypoxia and Correlates with Poor Clinical Outcomes

  2018cites this paper
• Targeting fibroblast activation protein in cancer - Prospects and caveats.

  2018cites this paper
• Polaprezinc inhibits liver fibrosis and proliferation in hepatocellular carcinoma.

  2017cites this paper
• Extracellular Matrix Regulates Fibroblast Heterogeneity and Tumorigenesis

  2017cites this paper
• Transforming Growth Factor &bgr; is a Poor Prognostic Factor and Inhibits the Favorable Prognostic Value of CD8+ CTL in Human Hepatocellular Carcinoma

  2017cites this paper
• Extracellular matrix directs phenotypic heterogeneity of activated fibroblasts.

  2017cites this paper
• The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer.

  2017cites this paper
• Clinicopathologic and prognostic significance of regulatory T cells in patients with hepatocellular carcinoma: a meta-analysis

  2017influential citation
• Fibroblast Activation Protein-α-Positive Fibroblasts Promote Gastric Cancer Progression and Resistance to Immune Checkpoint Blockade

  2017cites this paper
• CCN1/Cyr61 enhances the function of hepatic stellate cells in promoting the progression of hepatocellular carcinoma

  2017cites this paper
• Role of the Microenvironment in Liver Metastasis: From Pre- to Prometastatic Niches

  2016cites this paper
• Tumor Stroma, Desmoplasia, and Stromagenesis

  2016cites this paper
• Prognostic significance of regulatory T lymphocytes in patients with hepatocellular carcinoma

  2016cites this paper
• Neuropeptide Y is a physiological substrate of fibroblast activation protein: Enzyme kinetics in blood plasma and expression of Y2R and Y5R in human liver cirrhosis and hepatocellular carcinoma.

  2016cites this paper
• Cellular prognostic markers in hepatocellular carcinoma.

  2015cites this paper
• Angiogenin Secretion From Hepatoma Cells Activates Hepatic Stellate Cells To Amplify A Self-Sustained Cycle Promoting Liver Cancer

  2015cites this paper
• Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma

  2015influential citation
• Causal Modeling of Cancer-Stromal Communication Identifies PAPPA as a Novel Stroma-Secreted Factor Activating NFκB Signaling in Hepatocellular Carcinoma

  2015cites this paper
• Fibroblast activation protein increases metastatic potential of fibrosarcoma line HT1080 through upregulation of integrin-mediated signaling pathways

  2015cites this paper
• The In�ammator�Microenvironment in �epatocellular Carcinoma : A Pivotal Role for Tumor-AssociatedMacrophages

  2015cites this paper
• Immunopathology of Hepatobiliary Tumors and Immunotherapy of Liver Cancers

  2015cites this paper
• Hepatic Stellate Cells and Liver Cancer

  2015cites this paper
• Causal modeling of stroma-cancer cell communication

  2015cites this paper